« previous next »
Pages: [1]

Author Topic: (Abst.) Severe disease activity in a patient w/MS after daclizumab discontinuation  (Read 113 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9839
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Severe disease activity in a patient w/MS after daclizumab discontinuation
« on: December 17, 2018, 10:02:37 am »

From PubMed, December 17, 2018--"Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation":


https://www.ncbi.nlm.nih.gov/pubmed/30554038

Daclizumab (Zinbryta) has been taken off the market. For some background, here is a thread from a few months ago about it:


https://msspeaks.createaforum.com/treatments/zinbryta-being-pulled-from-market-due-to-safety-concerns/msg2172/#msg2172

Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics